News tagged with diffuse large b cell lymphoma
Scientists identify possible gene target for treating a form of lymphoma
Researchers have identified a mutation in a gene that could lead to targeted therapies for certain lymphoma patients whose cure rates are currently poor. Mutation of the MYD88 gene was found to be one of the most frequent ...
Dec 22, 2010 |
not rated yet |
0
Microsoft co-founder Allen treated for lymphoma
(AP) -- Microsoft Corp. co-founder and billionaire investor Paul Allen has been diagnosed with non-Hodgkin's lymphoma and is undergoing chemotherapy.
Nov 17, 2009 |
not rated yet |
0
Anti-inflammatory drugs may defeat a treatment-resistant type of cancer
(PhysOrg.com) -- Effective drugs for treating a chemotherapy-resistant form of lymphoma might already be on the market according to a study that has pieced together a chemical pathway involved in the disease.
Jun 24, 2009 |
5 / 5 (1) |
0
Search results for diffuse large b cell lymphoma
Epizyme identifies novel opportunity for treatment of genetically defined human B-cell lymphomas
Epizyme, Inc., a company leading the discovery and development of first-in-class, targeted cancer therapeutics against epigenetic targets, today announced the publication of breakthrough new research in the Proceedings of ...
Nov 15, 2010 |
not rated yet |
0
New lymphoma therapy may be more effective with fewer side effects
Diffuse large B-cell lymphoma (DLBCL) is a type of aggressive non-Hodgkin's lymphoma that accounts for approximately 40 percent of lymphomas among adults. If left untreated, it is fatal. The existing treatments have a cure ...
Nov 03, 2010 |
5 / 5 (2) |
0
New antibody-combination therapy boosts human lymphoma cure rate in mouse models
(PhysOrg.com) -- More than half of laboratory mice with human non-Hodgkin's lymphoma are cured by a treatment involving just two monoclonal antibodies, according to a new study.
Sep 02, 2010 |
not rated yet |
0
Lifestyle factors significantly impact survival of non-Hodgkin's lymphoma patients, study finds
A new study led by researchers from Mayo Clinic in collaboration with six other U.S. institutions has found that patients with non-Hodgkin's lymphoma who smoked, consumed alcohol or were obese before their cancer diagnosis ...
May 13, 2010 |
not rated yet |
0
Scientists design new drug type to kill lymphoma cells
A new type of drug designed to kill non-Hodgkin lymphoma tumor cells could lead to potential nontoxic therapies for cancer patients.
May 11, 2010 |
5 / 5 (3) |
0
Small molecule targets B cell lymphoma
Scientists are one step closer to developing a targeted therapy for lymphoma. New research, published by Cell Press in the April 13th issue of the journal Cancer Cell, identifies a specific small-molecule inhibitor that w ...
Apr 12, 2010 |
5 / 5 (2) |
0
New cancer treatment gives hope to lymphoma and leukemia patients
Cancer researchers have high hopes for a new therapy for patients with certain types of lymphoma and leukemia.
Feb 26, 2010 |
4.3 / 5 (3) |
0
Vitamin D levels associated with survival in lymphoma patients
A new study has found that the amount of vitamin D in patients being treated for diffuse large B-cell lymphoma was strongly associated with cancer progression and overall survival. The results will be presented at the annual ...
Dec 05, 2009 |
4.7 / 5 (3) |
1
New cancer target for non-Hodgkin's lymphoma
Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, ...
Nov 22, 2009 |
5 / 5 (1) |
0
Drugs to treat anemia in cancer patients linked to thromboembolism
Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., ...
Nov 10, 2009 |
2.5 / 5 (2) |
1
List of search results for diffuse large b cell lymphoma
